Moclobemide is a recently introduced short-acting, selective and reversible monoamine oxidase inhibitor, type A, with few and mild side-effects at therapeutic doses. Fifteen reported cases of moclobemide overdose were studied in detail and are presented here. While pure mechanism overdosage seems benign, a combination with tricyclic antidepressants may result in serious poisoning even when the moclobemide overdose is modest.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-2796.1993.tb00662.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!